235 related articles for article (PubMed ID: 22798675)
61. Melanocortin 1 Receptor-derived peptides are efficiently recognized by cytotoxic T lymphocytes from melanoma patients.
González FE; Ramírez M; Allerbring EB; Fasching N; Lundqvist A; Poschke I; Achour A; Salazar-Onfray F
Immunobiology; 2014 Mar; 219(3):189-97. PubMed ID: 24192537
[TBL] [Abstract][Full Text] [Related]
62. Peptide Super-Agonist Enhances T-Cell Responses to Melanoma.
Galloway SAE; Dolton G; Attaf M; Wall A; Fuller A; Rius C; Bianchi V; Theaker S; Lloyd A; Caillaud ME; Svane IM; Donia M; Cole DK; Szomolay B; Rizkallah P; Sewell AK
Front Immunol; 2019; 10():319. PubMed ID: 30930889
[TBL] [Abstract][Full Text] [Related]
63. Specificity, T cell receptor diversity and activation requirements of CD4+ and CD8+ clones derived from human melanoma-infiltrating lymphocytes.
Pandolfino MC; Viret C; Gervois N; Guilloux Y; Davodeau F; Diez E; Jotereau F
Eur J Immunol; 1992 Jul; 22(7):1795-802. PubMed ID: 1623924
[TBL] [Abstract][Full Text] [Related]
64. In vivo modulation of the distribution of thymocyte subsets: effects of estrogen on the expression of different T cell receptor V beta gene families in CD4-, CD8- thymocytes.
Screpanti I; Meco D; Morrone S; Gulino A; Mathieson BJ; Frati L
Cell Immunol; 1991 May; 134(2):414-26. PubMed ID: 1708703
[TBL] [Abstract][Full Text] [Related]
65. Characterization of the CD4+ and CD8+ tumor infiltrating lymphocytes propagated with bispecific monoclonal antibodies.
Wong JT; Pinto CE; Gifford JD; Kurnick JT; Kradin RL
J Immunol; 1989 Nov; 143(10):3404-11. PubMed ID: 2509557
[TBL] [Abstract][Full Text] [Related]
66. Identification of an enriched CD4+ CD8alpha++ CD8beta+ T-cell subset among tumor-infiltrating lymphocytes in human renal cell carcinoma.
Van den Hove LE; Van Gool SW; Van Poppel H; Baert L; Coorevits L; Van Damme B; Dal Cin P; Van den Berghe H; Ceuppens JL
Int J Cancer; 1997 Apr; 71(2):178-82. PubMed ID: 9139839
[TBL] [Abstract][Full Text] [Related]
67. A novel vascular targeting strategy for brain-derived endothelial cells using a TCR mimic antibody.
Bhattacharya R; Xu Y; Rahman MA; Couraud PO; Romero IA; Weksler BB; Weidanz JA; Bickel U
J Cell Physiol; 2010 Nov; 225(3):664-72. PubMed ID: 20506235
[TBL] [Abstract][Full Text] [Related]
68. T-Cell Therapy Enabling Adenoviruses Coding for IL2 and TNFα Induce Systemic Immunomodulation in Mice With Spontaneous Melanoma.
Tähtinen S; Blattner C; Vähä-Koskela M; Saha D; Siurala M; Parviainen S; Utikal J; Kanerva A; Umansky V; Hemminki A
J Immunother; 2016; 39(9):343-354. PubMed ID: 27741089
[TBL] [Abstract][Full Text] [Related]
69. Human effector T cells derived from central memory cells rather than CD8(+)T cells modified by tumor-specific TCR gene transfer possess superior traits for adoptive immunotherapy.
Wu F; Zhang W; Shao H; Bo H; Shen H; Li J; Liu Y; Wang T; Ma W; Huang S
Cancer Lett; 2013 Oct; 339(2):195-207. PubMed ID: 23791878
[TBL] [Abstract][Full Text] [Related]
70. CD8-mediated type 1 antitumor responses selectively modulate endogenous differentiated and nondifferentiated T cell localization, activation, and function in progressive breast cancer.
Dobrzanski MJ; Reome JB; Hylind JC; Rewers-Felkins KA
J Immunol; 2006 Dec; 177(11):8191-201. PubMed ID: 17114496
[TBL] [Abstract][Full Text] [Related]
71. Naive CD4+ T cells confer idiotype-specific tumor resistance in the absence of antibodies.
Bogen B; Munthe L; Sollien A; Hofgaard P; Omholt H; Dagnaes F; Dembic Z; Lauritzsen GF
Eur J Immunol; 1995 Nov; 25(11):3079-86. PubMed ID: 7489746
[TBL] [Abstract][Full Text] [Related]
72. Alloantigen-specific cytotoxic clones bearing the alpha,beta T cell antigen receptor but not CD4 or CD8 molecules.
Rivas A; Koide J; Laus R; Engleman EG
J Immunol; 1990 Jul; 145(2):470-6. PubMed ID: 2142178
[TBL] [Abstract][Full Text] [Related]
73. Ligand density determines the efficiency of negative selection in the thymus.
Römermann D; Heath WR; Allison J; Bayer B; Sorge Y; Miller JF; Hoffmann MW
Transplantation; 2001 Jul; 72(2):305-11. PubMed ID: 11477358
[TBL] [Abstract][Full Text] [Related]
74. Multiple sub-sets of CD4+ and CD8+ cytotoxic T-cell clones directed to autologous human melanoma identified by cytokine profiles.
Maccalli C; Mortarini R; Parmiani G; Anichini A
Int J Cancer; 1994 Apr; 57(1):56-62. PubMed ID: 7908659
[TBL] [Abstract][Full Text] [Related]
75. Absence of programmed death receptor 1 alters thymic development and enhances generation of CD4/CD8 double-negative TCR-transgenic T cells.
Blank C; Brown I; Marks R; Nishimura H; Honjo T; Gajewski TF
J Immunol; 2003 Nov; 171(9):4574-81. PubMed ID: 14568931
[TBL] [Abstract][Full Text] [Related]
76. Blocking TCR restimulation induced necroptosis in adoptively transferred T cells improves tumor control.
Kesarwani P; Chakraborty P; Gudi R; Chatterjee S; Scurti G; Toth K; Simms P; Husain M; Armeson K; Husain S; Garrett-Mayer E; Vasu C; Nishimura MI; Mehrotra S
Oncotarget; 2016 Oct; 7(43):69371-69383. PubMed ID: 27750220
[TBL] [Abstract][Full Text] [Related]
77. Distinct differentiative stages of CD4+CD8+ thymocyte development defined by the lack of coreceptor binding in positive selection.
Dutz JP; Ong CJ; Marth J; Teh HS
J Immunol; 1995 Mar; 154(6):2588-99. PubMed ID: 7533178
[TBL] [Abstract][Full Text] [Related]
78. Interplay between the TCR/CD3 complex and CD4 or CD8 in the activation of cytotoxic T lymphocytes.
de Vries JE; Yssel H; Spits H
Immunol Rev; 1989 Jun; 109():119-41. PubMed ID: 2527803
[TBL] [Abstract][Full Text] [Related]
79. MHC class I-selected CD4-CD8-TCR-alpha beta+ T cells are a potential source of IL-4 during primary immune response.
Leite-de-Moraes MC; Herbelin A; Machavoine F; Vicari A; Gombert JM; Papiernik M; Dy M
J Immunol; 1995 Nov; 155(10):4544-50. PubMed ID: 7594451
[TBL] [Abstract][Full Text] [Related]
80. Identification of α-fetoprotein-specific T-cell receptors for hepatocellular carcinoma immunotherapy.
Zhu W; Peng Y; Wang L; Hong Y; Jiang X; Li Q; Liu H; Huang L; Wu J; Celis E; Merchen T; Kruse E; He Y
Hepatology; 2018 Aug; 68(2):574-589. PubMed ID: 29443377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
